Abiomed Inc (NASDAQ:ABMD)

302.65
Delayed Data
As of Apr 23
 -3.27 / -1.07%
Today’s Change
123.60
Today|||52-Week Range
309.28
+61.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$13.0B

Company Description

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA.

Contact Information

ABIOMED, Inc.
22 Cherry Hill Drive
Danvers Massachusetts 01923
P:(978) 646-1400
Investor Relations:
(978) 676-1590

Employees

Shareholders

Mutual fund holders50.30%
Other institutional37.28%
Individual stakeholders16.78%

Top Executives

Michael R. MinogueChairman, President & Chief Executive Officer
David M. WeberChief Operating Officer
Todd A. TrappChief Financial Officer & Vice President
Thorsten SiessChief Technology Officer
Seth BilazarianChief Medical Officer